GRNA
$0.3
Revenue | $3.82Mn |
Net Profits | $-28.04Mn |
Net Profit Margins | -734.11% |
GreenLight Biosciences Holdings’s revenue jumped 1386.38% since last year same period to $3.82Mn in the Q1 2023. On a quarterly growth basis, GreenLight Biosciences Holdings has generated 26.36% jump in its revenue since last 3-months.
GreenLight Biosciences Holdings’s net profit jumped 26.6% since last year same period to $-28.04Mn in the Q1 2023. On a quarterly growth basis, GreenLight Biosciences Holdings has generated 27.66% jump in its net profits since last 3-months.
GreenLight Biosciences Holdings’s net profit margin jumped 95.06% since last year same period to -734.11% in the Q1 2023. On a quarterly growth basis, GreenLight Biosciences Holdings has generated 42.75% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.24 |
EPS Estimate Current Year | -0.24 |
GreenLight Biosciences Holdings’s earning per share (EPS) estimates for the current quarter stand at -0.24 - a 10.13% jump from last quarter’s estimates.
GreenLight Biosciences Holdings’s earning per share (EPS) estimates for the current year stand at -0.24.
Earning Per Share (EPS) | 0 |
GreenLight Biosciences Holdings’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q2 2023. This indicates that the GreenLight Biosciences Holdings has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-05-11 | -0.26 | 0 | 100% |
2023-08-30 | -0.24 | 0 | 100% |